comparemela.com

Latest Breaking News On - New zealand asthma awareness day - Page 1 : comparemela.com

Medical Research Institute Of New Zealand Explores Ground-breaking New Way Of Treating Asthma

Thursday, 15 July 2021, 2:42 pm The Medical Research Institute of New Zealand (MRINZ) has dedicated much of its research focus over the last two decades to the prevention and management of asthma, both here at home in Aotearoa, New Zealand and around the world. MRINZ’s asthma research has included three landmark studies which have shown that a 2 in1 inhaler, containing both a preventer and reliever medication, is far more effective than the traditional single reliever inhaler, which has been the basis of asthma management for over 60 years. These MRINZ studies have shown that the as-needed use of the combined 2 in 1 inhaler, referred to as

Wellington
New-zealand-general
New-zealand
Symbicort-turbuhaler
Graeme-hansen
Richard-beasley
Pepa-bruce
Research-institute-of-new-zealand-on-infopages
Research-organisation
Citizen-community
Asthma-research
Foundation-for-public-interest-journalism

Community Scoop » Medical Research Institute Of New Zealand Explores Ground-breaking New Way Of Treating Asthma

Community Scoop » Medical Research Institute Of New Zealand Explores Ground-breaking New Way Of Treating Asthma
scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.

Wellington
New-zealand-general
New-zealand
Symbicort-turbuhaler
Graeme-hansen
Richard-beasley
Pepa-bruce
Asthma-research
Research-institute-of-new-zealand
Clinical-research
Global-initiative-for-asthma
Research-organisation

Two in one asthma treatment gets global acclaim

Two in one asthma treatment gets global acclaim 04 May 2021 11:48 AM More Related Stories A New Zealand-developed approach to managing asthma is being picked up internationally. Asthma and Respiratory Foundation medical director James Fingleton says the latest guidelines from GINA, the Global Initiative for Asthma, recommend 2 in 1 reliever therapy, in which patients receive both a preventer and reliever treatment at the same time. The foundation adopted the approach last year based on three large randomised trials, and Dr Fingleton says it’s considered the biggest paradigm advance in the management of asthma for decades. New Zealand’s asthma statistics remain among the worst in the world, with one in seven children and one in eight adults living with asthma, and Māori tamariki, mokopuna and whānau disproportionately affected.

New-zealand
James-fingleton
Global-initiative-for-asthma
New-zealand-developed
Respiratory-foundation
Global-initiative
New-zealand-asthma-awareness-day
National
Regional
புதியது-ஜீலாந்து
ஜேம்ஸ்-விரல்
உலகளாவிய-முயற்சி-க்கு-ஆஸ்துமா

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.